MSB 5.63% $1.01 mesoblast limited

Leadership Change At Teva Provides Catalyst For Pharmaceutical...

  1. 497 Posts.
    lightbulb Created with Sketch. 3
    Leadership Change At Teva Provides Catalyst For Pharmaceutical Giant To Get Even Bigger, and Better

    http://www.forbes.com/sites/genemarcial/2012/04/19/leadeship-change-at-teva-provides-catalyst-for-pharmaceutical-giant-to-get-even-bigger-and-better/

    Article in Forbes Mag on TEVA

    Mentions Revascor in TEVA's pipeline.

    Good Luck

    DYOR
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
-0.060(5.63%)
Mkt cap ! $1.141B
Open High Low Value Volume
$1.04 $1.04 99.5¢ $3.318M 3.280M

Buyers (Bids)

No. Vol. Price($)
42 63359 $1.00
 

Sellers (Offers)

Price($) Vol. No.
$1.01 48726 17
View Market Depth
Last trade - 15.42pm 04/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.